GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Polaris AI Pharma Corp (XKRX:041910) » Definitions » Change In Receivables

Polaris AI Pharma (XKRX:041910) Change In Receivables : ₩1,392 Mil (TTM As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Polaris AI Pharma Change In Receivables?

Polaris AI Pharma's change in receivables for the quarter that ended in Sep. 2024 was ₩4,199 Mil. It means Polaris AI Pharma's Accounts Receivable declined by ₩4,199 Mil from Jun. 2024 to Sep. 2024 .

Polaris AI Pharma's change in receivables for the fiscal year that ended in Dec. 2023 was ₩-1,456 Mil. It means Polaris AI Pharma's Accounts Receivable increased by ₩1,456 Mil from Dec. 2022 to Dec. 2023 .

Polaris AI Pharma's Accounts Receivable for the quarter that ended in Sep. 2024 was ₩12,616 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Polaris AI Pharma's Days Sales Outstanding for the three months ended in Sep. 2024 was 81.45.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Polaris AI Pharma's liquidation value for the three months ended in Sep. 2024 was ₩54,411 Mil.


Polaris AI Pharma Change In Receivables Historical Data

The historical data trend for Polaris AI Pharma's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polaris AI Pharma Change In Receivables Chart

Polaris AI Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,218.11 -1,028.58 -2,789.82 167.98 -1,455.55

Polaris AI Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 721.25 -1,521.80 550.61 -1,835.54 4,198.82

Polaris AI Pharma Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,392 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Polaris AI Pharma  (XKRX:041910) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Polaris AI Pharma's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=12616.007/14134.259*91
=81.45

2. In Ben Graham's calculation of liquidation value, Polaris AI Pharma's accounts receivable are only considered to be worth 75% of book value:

Polaris AI Pharma's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=40964.591-6591.078+0.75 * 12616.007+0.5 * 21151.417
=54,411

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Polaris AI Pharma Change In Receivables Related Terms

Thank you for viewing the detailed overview of Polaris AI Pharma's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Polaris AI Pharma Business Description

Traded in Other Exchanges
N/A
Address
25 Balangongdan-ro, Hyangnam-eup, Gyeonggi-do, Hwaseong-si, KOR
Polaris AI Pharma Corp is engaged in the production of raw pharmaceutical ingredients. It focuses on generic drugs and produces about 40 types of raw medicines, including asthma treatments, gastric ulcer treatments, and alcohol dependence treatments, and supplies them domestically and internationally.

Polaris AI Pharma Headlines

No Headlines